ID
11995
Beskrivning
Efficacy of 5 Weeks of Treatment With BGG492 in Patients With Spasticity Due to Multiple Sclerosis; ODM derived from: https://clinicaltrials.gov/show/NCT01649050
Länk
https://clinicaltrials.gov/show/NCT01649050
Nyckelord
Versioner (1)
- 2015-08-30 2015-08-30 -
Uppladdad den
30 augusti 2015
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Muscle Spasticity Due to Multiple Sclerosis NCT01649050
Eligibility Muscle Spasticity Due to Multiple Sclerosis NCT01649050
- StudyEvent: Eligibility
Beskrivning
Exclusion Criteria
Alias
- UMLS CUI-1
- C0680251
Beskrivning
Patients with symptoms of spasticity not due to MS.
Datatyp
boolean
Alias
- UMLS CUI [1]
- C0026838
Beskrivning
Patients taking three or more different anti-spasticity medications.
Datatyp
boolean
Alias
- UMLS CUI [1]
- C0013227
- UMLS CUI [2]
- C0026838
Beskrivning
Acute MS exacerbation requiring treatment within 3 months of the Screening Visit.
Datatyp
boolean
Alias
- UMLS CUI [1]
- C0235874
- UMLS CUI [2]
- C0026769
Beskrivning
Initiation of, or the discontinuation of interferon beta or any other disease modifying therapy for MS within 3 months of the Screening Visit.
Datatyp
boolean
Alias
- UMLS CUI [1]
- C0015980
Beskrivning
Use of baclofen pump at any time.
Datatyp
boolean
Alias
- UMLS CUI [1]
- C3836732
Beskrivning
Wheelchair or bed-bound patients.
Datatyp
boolean
Alias
- UMLS CUI [1]
- C0043143
Similar models
Eligibility Muscle Spasticity Due to Multiple Sclerosis NCT01649050
- StudyEvent: Eligibility
C0332307 (UMLS CUI [2])
C0026769 (UMLS CUI [2])
C0026769 (UMLS CUI [2])
C0026838 (UMLS CUI [2])
C0026769 (UMLS CUI [2])